Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank93
3Y CAGR+23.3%
5Y CAGR+29.3%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+23.3%/yr
Annual compound
5Y CAGR
+29.3%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $466.88M | -16.2% |
| 2024 | $557.13M | +59.9% |
| 2023 | $348.33M | +39.9% |
| 2022 | $248.92M | +0.2% |
| 2021 | $248.52M | +92.2% |
| 2020 | $129.30M | +279.0% |
| 2019 | $-72.25M | +9.5% |
| 2018 | $-79.79M | -229.5% |
| 2017 | $61.61M | +160.5% |
| 2016 | $-101.86M | - |